Madan Ajay

Chief Development Officer at CRNX

Sold, on record
$239k
Dollars the filings state
Form 4 sales
1
Latest Feb 7, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • CRNXCrinetics Pharmaceuticals, Inc.Chief Development Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale CRNXPlan not stated
    Feb 7, 2022 2022

    Sold 13,411 shares at $17.83 ($239k)

    Madan Ajay, Chief Development Officer

    Sold 7.2% of holdings ($3.3M position)172,045 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Madan Ajay
Source
Feb 7, 2022Feb 9, 2022CRNXChief Development OfficerForm 4 sale13,411$239k7.2%Plan not statedSEC